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Abstract
Since inflammatory mechanisms have been postulated to link obesity to osteoarthritis, the current
study evaluated the ratio of immune cells to multipotent stromal cells within the infrapatellar fat
pad (IPFP) and subcutaneous adipose tissue (SQ) of the knee; each depot has potential as a source
of regenerative cells. The immunophenotypes of stromal vascular fraction (SVF) and adipose-derived
stem cells (ASCs) of the IPFP and SQ were determined in tissues from osteoarthritic subjects (n=7)
undergoing total knee replacement. Based on a subset of surface antigens, the immunophenotype of
ASCs from SQ of OA subjects was not significantly different from that of relatively healthy and leaner
subjects undergoing elective liposuction surgery. Flow-cytometry comparison of SVF cell populations
in the IPFP of OA subjects resembled those within the subject’s own matched SQ, with the exception
of the endothelial marker CD31+, which was significantly greater in cells from SQ. In the OA subjects,
lower numbers of capillary-like structures and higher numbers of stromal and alkaline phosphatase
colony-forming units in the IPFP vs SQ were consistent with this finding; however, ASCs from both
depots in OA subjects exhibited comparable adipogenic and osteogenic differentiation potential.
Thus, the IPFP contains an ASC and immune cell population similar to that of donor-matched SQ,
making it an alternative ASC source for tissue regeneration. Further studies will be needed to
determine whether IPFP immune cell infiltrates play an aetiological role in osteoarthritis equivalent
to that shown in diabetes associated with obesity. Copyright © 2012 John Wiley & Sons, Ltd.
Received 2 December 2011; Accepted 6 June 2012
Supporting information may be found in the online version of this article.
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1. Introduction
Adipose tissue is widely distributed throughout the human
body. It not only functions as an endocrine organ but also
has anti-inflammatory and immunomodulatory characteris-
tics. Secretion of trophic factors, such as adiponectin and
leptin, by adipose tissue influences other hormonal pathways
in the body. In addition to its secretory activity, adipose tissue
plays a role in regulating energy metabolism as well as
neuroendocrine and immune functions via a feedback loop
with the central nervous system. The stromal vascular
fraction (SVF), an isolated cell pellet obtained after
enzymatic digestion and centrifugation of a tissue sample,
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contains multiple cell lineages, including pre-adipocytes,
endothelial cells, mesenchymal stem cells (MSCs) and
leukocytes. T cells, a subset of leukocytes, recognize specific
antigens with a specific cell surface antigen T cell receptor
(TCR) (Liossis and Tsokos, 1998). This recognition by Tcells
leads to the activation, proliferation and secretion of cyto-
kines and growth factors. These T cell populations reside in
adipose tissue and contribute to the systemic inflammation
observed with obesity.
The infrapatellar or Hoffa’s fat pad (IPFP) is an
intracapsular, extrasynovial structure within the knee
that lies directly posterior to the patellar tendon (Saddik
et al., 2004). It is routinely removed during knee replace-
ment surgery, and may serve as a unique source of ASCs
from previously discarded tissue. Unlike subcutaneous
adipose tissue (SQ), which is viewed primarily as an
endocrine and metabolic depot, the infrapatellar fat
pad has a unique role as a mechanical fat depot (Clockaerts
et al., 2010). In addition to the degenerative changes
throughout the knee, osteoarthritis (OA) affects the
infrapatellar fat pad via inflammation mediated by T
cell-induced cytokine cascades (Clockaerts et al., 2010).
T cells are believed to play a significant role in the onset
and progression of knee OA through pro-inflammatory
cytokine release and subsequent activation of macro-
phage populations within adipose tissue (Sakkas and
Platsoucas, 2007; Yang et al., 2010). The T cells interact
with and activate several cell types, including macro-
phages, monocytes, chondrocytes and osteoclasts,
through either soluble mediators or direct interaction.
T cell activation can also contribute to joint destruction
in OA by both inducing the production of collagenase,
an enzyme responsible for cleaving peptide bonds in
collagen, and triggering apoptosis of chondrocytes in
the knee cartilage (Yang et al., 2010).
Inflammatory changes in adipose tissue are not limited to
the IPFP. Peripheral and visceral adipose depots exhibit
inflammatory changes in the context ofmetabolic syndrome,
obesity and diabetes (Apovian et al., 2008; Kloting et al.,
2010; Strissel et al., 2007; Weisberg et al., 2003; Xu et al.,
2003). Adipose tissue from obese subjects displays an
increased density of macrophages or ‘crown’ cells (Apovian
et al., 2008; Kloting et al., 2010; Strissel et al., 2007;
Weisberg et al., 2003; Xu et al., 2003), as well as distinct
T cell populations relative to lean individuals (Feuerer
et al., 2009; Nishimura et al., 2009; Duffaut et al., 2009b;
Winer et al., 2009; Yang et al., 2010). A growing body of
literature supports a role for T cell-derived cytokines as
causative agents in the onset and progression of metabolic
syndrome locally within the adipose tissue (Duffaut et al.,
2009a, 2009b; Yang et al., 2010).
We therefore asked: (a) whether osteoarthritis alters the
subcutaneous adipose cell population as compared to a
relatively healthy subject undergoing elective liposuction;
and (b) whether the IPFP from osteoarthritic subjects would
exhibit cell populations similar to that of donor-matched
subcutaneous adipose tissue. To address these questions,
the immunophenotype of the SVF cells and adherent,
culture-expanded adipose-derived stromal/stem cells (ASCs)
isolated from the IPFP and subcutaneous adipose tissue of
patients undergoing total knee replacement were compared
to each other and to liposuction aspirates from healthy
individuals.
2. Methods
2.1. Institutional review board and patient
evaluation
All specimens were collected under protocols reviewed and
approved by institutional review boards at the Louisiana State
University School of Medicine–New Orleans (LSUHSC-NO;
Protocol No. 7248) and the Pennington Biomedical
Research Center (PBRC; Protocols Nos 10007 and 23040).
Studies were conducted in accordance with the 1964
Declaration of Helsinki and with US HIPAA requirements.
Patients undergoing total knee replacement were evaluated
with respect to their medical history and physical examina-
tion for evidence of diabetes and metabolic disease, hyper-
tension and osteoarthritis. Radiological evaluation was
used to grade for the Kellgren–Lawrence score, which
measures joint narrowing, osteophyte formation and
deformity of bone contours (Kellgren and Lawrence, 1957).
2.2. Serum analysis
Blood serum samples were collected from osteoarthritic sub-
jects undergoing elective knee replacement (n=9) or from
subjects undergoing elective liposuction or bariatric surgery
(n=30) and transported to the clinical chemistry laboratory
at PBRC for further analysis (Table 1). Of the osteoarthritic
subjects, 33% of the donors were diabetic and 66% were
hypertensive. The Homeostasis Model of Assessment –
Insulin Resistance (HOMA-IR) was calculated as follows:
fasting insulin (mU/ml) fasting glucose (mg/dl)/405. All
blood samples were collected from fasting glucose levels.
2.3. SVF cells and ASCs isolation and expansion
The samples were transported to Pennington Biomedical on
the day of the procedure. Infrapatellar fat pad, periarticular
Table 1. Donor demographics and serum analysis data
Subjects OA Controls p
Donor number 9 30
Donor age 64.418.0 43.811.1 0.09
BMI 34.38.7 25.83.9 0.019
Kellergen–Lawrence score 3.41.2 ND
Glucose (mg/dl) 113.621.0 79.617.7 0.001
Cholesterol (mg/dl) 161.321.0 179.129.6 0.275
HDL (mg/dl) 46.115.7 59.212.9 0.042
LDL (mg/dl) 90.827.6 101.325.0 0.328
HOMA-IR 3.02.9 1.01.6 0.076
Insulin (mU/ml) 9.86.8 4.97.5 0.085
Triglyceride (mg/dl) 122.343.1 93.145.6 0.102
ND, not done; OA, osteoarthritis.
758 P. P. de Carvalho et al.
Copyright © 2012 John Wiley & Sons, Ltd. J Tissue Eng Regen Med 2014; 8: 757–762.
DOI: 10.1002/term
subcutaneous adipose tissue and blood serum samples were
collected from osteoarthritic subjects (n=9 total for serum
analysis, n=6–7 used in cell culture and flow-cytometry
data analysis) undergoing total knee replacement. After
weighing, the IPFP and SQ samples were minced, washed
two or three times with phosphate-buffered saline (PBS)
and digested in a volume of 2ml collagenase digest: 1 g
tissue (20ml PBS, 20ml 2mM calcium chloride, 20mg
collagenase, 200mg albumin) in a rocker dry oven at
37 C for 1h. Following digestion, the samples were
centrifuged twice at 300 g for 5min, filtered using a
100mM filter and centrifuged again at 300 g for 5min to
obtain the SVF. In order to remove erythrocytes from
the sample and decrease the total number of events in
flow-cytometry analysis, 5ml red blood cell lysis buffer
(200ml distilled water, 1.66 g ammonium chloride, 0.2 g
potassium bicarbonate, 0.605ml 0.25 M EDTA) was used;
20ml PBS was added to terminate RBC lysis. After
centrifugation at 300 g for 5min, the supernatent was
removed and the samples were resuspended in 5ml stromal
medium [DMEM/F-12, 10% fetal bovine serum (FBS;
Hyclone, Logan, UT, USA), 1% antibiotic/antimycotic (MP
Biomedicals, Solon, OH, USA)]. Following the processing
procedure, 20ml cell suspension from both samples was
stained with trypan blue (Sigma-Aldrich, St. Louis, MO,
USA) and counted using a haemocytometer. Cells from IPFP
(n=7) and SQ (n=6) obtained from osteoarthritic subjects
or subcutaneous lipoaspirate samples (n=3) from patients
undergoing elective cosmetic surgery were expanded and
differentiated along the adipocyte and osteoblast pathways
as previously described (Yu et al., 2010). Additionally,
fibroblast (CFU-F) and osteoblast (CFU-ALP) colony-
forming unit assayswere performed in six-well plates, where
individual wells were seeded with 50 or 100 passage 1 ASCs
from IPFP or SQ from osteoarthritic subjects, as previously
described (Staszkiewicz et al., 2010).
2.4. Flow cytometry
Flow-cytometry analysis (LSRII from BD Biosciences, San
Jose, CA, USA) was performed according to published
protocols (Yu et al., 2010). The SVF cells were analysed
immediately following the initial collagenase digestion
procedure, while the passage 2 ASCs were analysed
following culture expansion and trypsin release; no cells
were cryopreserved prior to analysis. If necessary, the
samples were diluted to the required concentration of
1106 cells/ml. The cells were washed in 10ml PBS and
centrifuged twice at 300 g for 5min, then resuspended
in 500ml cold PBS. The sample was transferred to a 1.5ml
microcentrifuge tube containing the 87ml mixture of
the 13-fluorochrome panel (see Supporting information,
Table S1). The stained samples were incubated in a dark
environment at room temperature for 30min. The cells
were then washed with 1ml PBS and 1% BSA and
centrifuged at 300 g for 3min, three times. They were
resuspended in 500ml 1% formaldehyde in PBS, stored
at 4 C, and transported to LSUHSC-NO within 48h for
flow-cytometry analysis.
2.5. Endothelial cell labelling
A 100–200mg piece of tissuewas sectioned from subcutaneous
adipose tissue and infrapatellar fat pad samples (n=3) and
transferred to a 1.5ml microcentrifuge tube; 1ml stock
solution of isolectin (500mg/ml) was diluted to 10mg/ml
and transferred to each sample. The sections were then
incubated in the dark for 1h with lectin fluorescein
isothiocyanate (FITC) conjugate from Ulex europaeus
(Sigma-Aldrich) (Pasarica et al., 2009). Samples were then
washed with PBS and analysed using a confocal micro-
scope. Vessel density was determined by superimposing an
image of each sample on a grid, using ImageJ software.
Vessel density was defined as the number of times a vessel
intersects a gridline within the specified area.
2.6. Statistics
Values are expressed as mean standard deviation (SD),
where statistical significance is determined by p values
0.05, based on Student’s t-test.
3. Results and discussion
Adipose tissue presents an accessible and abundant source of
adult stromal/stem cells for regenerative medical therapies
(Gimble et al., 2007). The majority of data on human SVF
cells and ASCs is from subcutaneous adipose tissue isolated
from relatively young and healthy subjects undergoing
elective liposuction surgery (Aust et al., 2004; Gimble et al.,
2007; Gronthos et al., 2001; McIntosh et al., 2006; Mitchell
et al., 2006; Yu et al., 2010; Zuk et al., 2002); however,
evaluation of cells isolated from subcutaneous adipose tissue
of osteoarthritic subjects is limited at best. Therefore, the first
research questionwas addressed by initial studies comparing
the demographics, serumprofile and SVF immunophenotype
between osteoarthritic patients undergoing knee replace-
ment and healthy elective liposuction subjects (Table 1; see
also Supporting information, Table S2). The osteoarthritic
population was significantly older than the healthy control
population (mean age 64.4 vs 43.8 years). With one excep-
tion, all knee replacement patientswere overweight or obese,
with a mean BMI of 34.3 (range 22.3–53.8), significantly
greater than that of the controls (mean BMI 25.8, range
20.9–34.5). Consistent with the fact that 33% of
osteoarthritic subjects were diabetic, their fasting glucose
levels were significantly elevated relative to controls, with a
trend towards increased triglyceride levels, insulin levels
and HOMA-IR, a derived value reflecting the level of insulin
sensitivity. While HDL levels were significantly higher in the
control relative to the osteoarthritic cohort, cholesterol and
LDL levels were comparable. The knee replacement cohort
displayed a mean Kellgren–Lawrence score of 3.4; this
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parameter was not evaluated in the liposuction cohort. The
immunophenotype of the stromal vascular fraction (SVF)
cells obtained from subcutaneous lipoaspirate samples
donated by healthy liposuction subjects (n=3) was similar
to that from SQ of osteoarthritic knees, based on expression
of a limited panel of endothelial (CD31), lymphoid (CD16,
CD56), myeloid (CD14) and stromal (CD29) surface
antigens (see Supporting information, Table S2). Although
the current study examined only three liposuction donors in
detail, the data obtained within this limited cohort were
consistent with our own previously published studies (with
n=5–7 up to n=64 subjects) (Aust et al., 2004; Gronthos
et al., 2001; McIntosh et al., 2006; Mitchell et al., 2006; Yu
et al., 2010) as well as that of others in the field (Katz et al.,
2005; Maumus et al., 2011; Zuk et al., 2002). These data sup-
port the conclusion that subcutaneous adipose tissue has a
similar potential as a stromal/stem cell source, independent
ofwhether it is obtained fromolder,more obese osteoarthritic
subjectswith a higher incidence of diabetes or younger, leaner
liposuction donors with no history of metabolic disease.
A number of studies in the literature have evaluated the
differentiation potential and immunophenotype of ASCs
isolated from the IPFP (Buckley et al., 2010a, 2010b;
Dragoo et al., 2003; Khan et al., 2008, 2009, 2010;
Wickham et al., 2003); however, only one study has
performed a side-by-side comparison between these cells
and bone marrow-derived MSCs (Vinardell et al., 2011)
and none has compared them to subcutaneous adipose-
derived ASCs. Therefore, the SVF cells and ASCs from
matched IPFP and SQ adipose tissue from osteoarthritic
subjects were compared in the second experiment of the
current study. Flow-cytometric analyses were performed
on the freshly isolated SVF cells from both depots, prior to
plastic adherence or culture expansion using a wide panel
of antibodies for lineage-specific antigens (Tables 2A
and 2B). Compared to the IPFP, SQ SVF cells displayed
significantly increased expression of the endothelial cell
marker CD31 (p=0.02), while other B cell (CD20),
memory/effector/regulatory Tcell (CD3, 4, 8, 25), myeloid
(CD14), natural killer cell (CD56, CD66) and mesenchymal
(CD29) antigens were comparable (Tables 2A and 2B; see
also Supporting information, Figure S1, Table S2). Flow
cytometry of trypsin-harvested passage 2 ASCs showed that
the immunophenotype was not significantly different
between matched IPFP and SQ depots of osteoarthritic
donors for expression of haematopoietic (CD34, CD45)
and stromal (CD29, CD44, CD73, CD90, CD105) antigens
(see Supporting information, Table S2). Values were
consistent with previous characterizations of passaged
human ASCs from subcutaneous depots of healthy donors
undergoing elective liposuction surgery (Gronthos et al.,
2001; McIntosh et al., 2006; Mitchell et al., 2006; Yu
et al., 2010).
Sakkas and Platsoucas (2007) and Sakkas et al. (1998)
found T cell aggregates in 65% of patients with OA, and
the T cells contribute to OA progression through release of
cytokines such as interferon-g and interleukin 2. The current
study confirms and extends this finding, documenting the
presence of a significant percentage of T cells within the
IPFP stromal vascular fraction, where CD3+CD8+ T cells
accounted for ~11% of the total population. With respect
to lymphoid and myeloid cell markers, the composition of
the IPFPwas not significantly different from that of matched
subcutaneous adipose tissue. While this suggests that the
local microenvironments are comparable with respect to
inflammation in both depots, additional evaluation of
cytokines and inflammatory biomarkers should be evaluated
in future comparisons of matched tissues.
Colony-forming unit assays compared passage 1 cells
from matched IPFP and SQ depots (n=6 donors) cultured
under osteogenic (CFU-ALP) or undifferentiated conditions
(CFU-F) (Figure 1 and Table 3). The CFU-F and CFU-ALP
frequencies were significantly greater by 1.33-fold and
1.37-fold, respectively, in the IPFP relative to subcutaneous
adipose tissue. Confocal photomicrographs of the lectin-
stained adipose tissues examined vascularization of subcuta-
neous adipose tissue relative to the IPFP (Figure S4). Image
analyses indicated that subcutaneous adipose tissue exhibited
22% more vessel intersections than IPFP (75.712.1 vs
62.314.6, n=3 donors); however, these findings did not
achieve significance (p=0.239, one-tailed t-test). The ASCs
Table 2A. Comparison of the stromal vascular fraction cell
immunophenotype in matched infrapatellar fat pad and
subcutaneous adipose tissue obtained from subjects undergoing
total knee replacement
Depot Marker Mean p
Subcutaneous CD14 %Parent 22.98.2 0.39
fat pad CD14 %Parent 17.913.6
Subcutaneous CD29+ %Parent 42.620 0.27
fat pad CD29+ %Parent 34.130.2
Subcutaneous CD31 %Parent 22.37.8 0.02
fat pad CD31 %Parent 9.95.1
Subcutaneous CD56 %Parent 16.212.1 0.29
fat pad CD56 %Parent 7.210.8
Subcutaneous CD3 %Parent 11.89.6 0.28
fat pad CD3 %Parent 6.64.5
Subcutaneous CD3+CD8+ %Parent 12.813.7 0.64
fat pad CD3+CD8+ %Parent 10.713.1
Subcutaneous CD16 %Parent 12.89.6 0.50
fat pad CD16 %Parent 8.613.9
Subcutaneous CD66 %Parent 6.612 0.25
fat pad CD66 %Parent 0.40.3
Subcutaneous CD20 %Parent 0.81.7 0.32
fat pad CD20 %Parent 0.20.4
Table 2B. Comparison of stromal vascular fraction immuno-
phenotypes in subcutaneous adipose tissue obtained from
subjects undergoing elective cosmetic surgery (lipoaspirate)
or total knee replacement (subcutaneous)
Sample Marker Mean p
Lipoaspirate CD14 %Parent 26.111.8 0.60
Subcutaneous CD14 %Parent 22.110.4
Lipoaspirate CD16 %Parent 8.94.4 0.83
Subcutaneous CD16 %Parent 10.711.5
Lipoaspirate CD56 %Parent 8.86.9 0.16
Subcutaneous CD56 %Parent 20.213.0
Lipoaspirate CD31 %Parent 26.713.4 0.52
Subcutaneous CD31 %Parent 20.75.6
Lipoaspirate CD29+ %Parent 45.819.8 0.41
Subcutaneous CD29+ %Parent 31.913.8
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from both depots differentiated along adipocyte and osteo-
blast lineages, based on oil red O or alizarin red histochemical
staining (see Supporting information, Figure S2), confirming
previous reports on the differentiation potential of IPFP- and
subcutaneous-derived ASCs (Dragoo et al., 2003; Khan et al.,
2008; Wickham et al., 2003; Yu et al., 2010).
We recognize certain limitations of this study. Ideally,
IPFP samples from the patients undergoing lipoaspiration
would have been the best control. However, harvesting this
tissue would have been unethical. Second, increased
sample size would allow for greater differentiation between
cohorts and control for various disease states. Additionally,
to obtain clinically relevant numbers of cells, the IPFPASCs
must be cultured beyond the current level of passage 2.
While prior studies from our laboratory have examined
subcutaneous ASCs from lipoaspirates up to passage 30,
studies with IPFP at extended passages are needed
(Izadpanah et al., 2006). Third, we did not compare the
circulating systemic and tissue-specific adipokine profiles in
matched IPFP and subcutaneous specimens. Nevertheless,
these findings support the conclusion that the infrapatellar
fat pad provides a potential source of ASCs for tissue
engineering and regenerative medical applications compara-
ble to that of subcutaneous adipose tissue (Dragoo et al.,
2003; Khan et al., 2008; Wickham et al., 2003). The ASCs
fromboth adipose depots aremultipotent, capable of differen-
tiating along the adipocyte and osteoblast lineage pathways.
Likewise, the IPFP ASCs display an immunophenotype
that is not significantly different from that of ASCs derived
from donor-matched subcutaneous adipose tissue. The
current data confirm and extend published studies document-
ing the multiple lineage differentiation potential of IPFP-
derived ASCs (Dragoo et al., 2003; Erickson et al., 2002;
Guilak et al., 2006; Halvorsen et al., 2001; Khan et al., 2008;
Wickham et al., 2003; Zuk et al., 2001, 2002). With
the growth of total knee replacements estimated to reach
3.5 million surgeries by 2030, the IPFP may serve as a safe,
low-cost and unique ASCs source for orthopaedic procedures
(Kurtz et al., 2007).
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Table 3. Comparative analysis of colony-forming unit frequency
in infrapatellar fat pad and subcutaneous adipose tissue
Tissue/CFU CFU-F CFU-ALP p
IPFD 23.34.9 25.78.4 410–4
SQ 17.53.9 18.86.0 310–3
The colony forming unit-fibroblast (CFU-F) and alkaline phosphatase+
(CFU-ALP) were determined for 100 passage 1 ASCs from infrapatellar
fat pad (IPFD) and subcutaneous (SQ) adipose tissue obtained from
n=6 donors. Values are expressed as the mean SD. p values
were determined based on Student’s t-test; no significant difference
(p<0.05) was determined between CFU-F and CFU-ALP values in a
single tissue (IPFD, SQ).
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